In Brief
This article was originally published in The Tan Sheet
Executive Summary
Imidazoline childproof package deadline extended; FDA wants to define food allergen thresholds; Danone cuts workforce in Europe; Primatene Mist bill voted down in the house; CARU urges WhoNu? ad off kids TV; Bayer recalls Bronkaid; Tate & Lyle to develop Nandi Proteins food ingredient; more news In Brief.
You may also be interested in...
Imidazoline Childproof Packaging Deadline Extended Six Months, Potentially More
The Consumer Product Safety Commission followed its staff’s recommendation to extend the deadline for six months, through May 10, 2105, and to consider requests for additional six-month extensions on a case-by-case basis.
Imidazoline Childproof Packaging Deadline Extended Six Months, Potentially More
The Consumer Product Safety Commission followed its staff’s recommendation to extend the deadline for six months, through May 10, 2105, and to consider requests for additional six-month extensions on a case-by-case basis.
Armstrong Juggles Reformulating Primatene Mist, Pushing To Sell Existing Inventory
Armstrong Pharmaceuticals plans to submit in the fourth quarter an NDA to FDA for an OTC asthma inhaler reformulated without chlorofluorocarbon as a propellant. The House Energy and Power Subcommittee proposes allowing the firm to sell its remaining inventory of CFC-containing Primatene Mist.